Neoplasm Metastasis clinical trials
The registry lists 4,040 studies for Neoplasm Metastasis across more than 10 countries. 886 are recruiting or about to start. 1,466 of them are mainly about Neoplasm Metastasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Neoplastic Cells, Circulating: 4,544 studies, 1,029 open.
ClinicalTrials.gov finds 22,880 studies for Neoplasm Metastasis. How that becomes 4,037 here
This page counts the studies the registry files under Neoplasm Metastasis, and those it files under no condition that list Neoplasm Metastasisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 22,880Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −503Filed under a narrower condition, counted on its own pageNeoplastic Cells, Circulating 207 · Lymphatic Metastasis 202 · Neoplasms, Unknown Primary 94
- −1,310List Neoplasm Metastasis as a condition, but the registry did not file them under itMost often written as “Brain Metastases” (328), “Liver Metastases” (208), and “Bone Metastases” (79). The registry filed 14 of them under no condition at all, and the others under other conditions only, most often Brain Neoplasms (473) and Colorectal Neoplasms (210).
- −17,152Match it another way1,316 name it in the title, 243 in a keyword, and 15,593 by a synonym or other text the search reads.
- 3,915Counted here and found by its search317 of them list Neoplasm Metastasis in their own words; the registry filed them under no condition.
- +122
Counted here, but its search does not find them
- Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal LesionsNCT04242589
- A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation TherapyNCT05155423
- Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node MetastasesNCT07083648
- Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone MetastasesNCT01470105
- Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic DiseaseNCT05101824
- PK/PD Study of SHR-2017 Injection in Patients With Bone MetastasesNCT06380881
- Quantitative MRI for Functional Assessment Following SBRT for Spinal MetastasesNCT04248543
- Measuring Fatty Acid Oxidation in Cerebral Metastases Using [18F]FPIANCT04807582
- Multicentric European Study In Patients With Vertebral MetastasesNCT06220071
- Stereotactic Body Radiation Therapy (SBRT) for Liver MetsNCT01360606
- Palliation: the Effect of Education on PainNCT01358539
- Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal MetastasesNCT02512965
- Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL StudyNCT02364115
- Study of Different Gating Techniques for PET Image of Lung and Liver LesionsNCT05779865
- Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone MetastasesNCT01248585
- Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes MetastasesNCT02970955
- Feasibility of Preoperative Inspiratory Muscle Training for Patients With Peritoneal MetastasesNCT05665257
- Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)NCT00503178
- Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone MetastasesNCT01429493
- Validation of Novel Predictive Score for Patients With Spinal MetastasesNCT03224650
- 4,037The count on this page
Get an email when these change. Save the Neoplasm Metastasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
M.D. Anderson Cancer Center (135) · National Cancer Institute (NCI) (124) · Eli Lilly and Company (72) · Memorial Sloan Kettering Cancer Center (61) · AstraZeneca (54) · Novartis Pharmaceuticals (43) · Pfizer (42) · Fudan University (40)
What is being tested here
Drugs under test in Neoplasm Metastasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Immune checkpoint inhibitors 47 open · Tyrosine kinase inhibitors (TKIs) 43 open · Antibody-drug conjugates (ADCs) 21 open · Antimetabolites 18 open · Angiogenesis inhibitors 8 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Qilu Pharmaceutical Co., Ltd.
- Dec 2026A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy · Phase 3 · M.D. Anderson Cancer Center
- Dec 2026Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer · Phase 3 · M.D. Anderson Cancer Center
- Dec 2026A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC · Phase 3 · Sun Yat-sen University
- Mar 2027Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma · Phase 3 · TuHURA Biosciences, Inc.
- Mar 2027Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases · Phase 3 · Sun Yat-sen University
- Apr 2027Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. · Phase 3 · Taiho Oncology, Inc.
- Apr 2027Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma · Phase 3 · mAbxience Research S.L.
- Apr 2027Metastasis-directed Therapy for Oligorecurrent Prostate Cancer · Phase 3 · Universitaire Ziekenhuizen KU Leuven
- May 2027Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09) · Phase 3 · AstraZeneca
Who these studies take
Of the 688 Neoplasm Metastasis studies recruiting now, 536 (78%) set no upper age limit and 97 (14%) stop at 75 or younger. 48 (7%) take children under 18. 35 (5%) are for women only and 27 (4%) for men only; 18 (3%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 28 (4%) | 30 (4%) |
| 18 | 640 (93%) | 630 (92%) |
| 30 | 654 (95%) | 644 (94%) |
| 40 | 652 (95%) | 643 (93%) |
| 50 | 648 (94%) | 641 (93%) |
| 65 | 645 (94%) | 639 (93%) |
| 75 | 622 (90%) | 620 (90%) |
| 85 | 541 (79%) | 550 (80%) |
Across all 4,040 studies, recruiting or not: 11% stop at 75 or younger and 2% at 65; 7% take children; 8% are for women only and 5% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Neoplasm Metastasis studies take
Of 496 phase 1 interventional studies under Neoplasm Metastasis, half reached primary completion within 54 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 54 mo33–83 · 496 studies | 48 mo28–75 · 286 studies | 61 mo40–98 · 210 studies |
| Phase 1/2 | 62 mo41–89 · 213 studies | 56 mo41–89 · 127 studies | 65 mo43–90 · 86 studies |
| Phase 2 | 55 mo33–83 · 442 studies | 33 mo26–63 · 88 studies | 60 mo36–90 · 354 studies |
| Phase 2/3 | 56 mo43–98 · 27 studies | — | — |
| Phase 3 | 49 mo36–66 · 138 studies | 41 mo34–57 · 83 studies | 59 mo49–108 · 55 studies |
| Phase 4 | 53 mo22–68 · 24 studies | — | — |
| Interventional, no phase | 54 mo28–91 · 316 studies | — | 58 mo28–93 · 291 studies |
| Observational | 66 mo35–172 · 240 studies | — | 75 mo36–172 · 209 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting11
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyNov 10, 2026NCT07423117
- Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic CancerNov 6, 2026NCT07829185
- Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact LabNov 6, 2026NCT07860723
- Change in Fat Fraction Quantification Before and After Treatment in Bone MetastasesNov 4, 2026NCT07848516
- Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric PatientsNov 2, 2026NCT07658768
Show 6 moreShow fewer
- Pluvicto Real-world Investigation in Survival in Metastatic CRPCOct 30, 2026NCT07697989
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesOct 28, 2026NCT06549478
- Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot StudyOct 26, 2026NCT07474025
- A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast CancerOct 21, 2026NCT07658183
- FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)Oct 13, 2026NCT07815834
Results posted4
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseNov 5, 2026NCT01552434
- Radiosensitizing Chemotherapy withSBRT for the Treatment of Inoperable Liver and/or Lung Metastases of CRCOct 30, 2026NCT01220063
- Genetic Testing in Guiding Treatment for Patients With Brain MetastasesOct 30, 2026NCT03994796
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTENOct 27, 2026NCT04317105
Stopped4
- Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With TebentafuspWithdrawnNov 6, 2026NCT07803562
- FS120 Phase 1/1b Study in Patients With Advanced MalignanciesTerminatedNov 5, 2026NCT04648202
- CT-95 in Advanced Cancers Associated With Mesothelin ExpressionTerminatedNov 5, 2026NCT06756035
- SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular CarcinomaSuspendedOct 15, 2026NCT07274774
Newly registered20
- A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNov 10, 2026NCT07928037
- Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer PatientsNov 10, 2026NCT07928167
- A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic CancerNov 10, 2026NCT07928362
- Effect of Squatting Position in the Second Stage of Labor on Birth OutcomesNov 5, 2026NCT07918872
- Ultrasonographic Tissue Thickness After Complex Decongestive Therapy in Lower-Limb LymphedemaNov 5, 2026NCT07919834
Show 15 moreShow fewer
- Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)Nov 5, 2026NCT07920198
- CR-002 in Adult Participants With Locally Advanced or Metastatic Solid TumorsNov 2, 2026NCT07909031
- Station-Specific Lymph Node Metastasis After Neoadjuvant Chemoimmunotherapy for Middle Thoracic Esophageal Squamous Cell CarcinomaOct 29, 2026NCT07902544
- A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.Oct 29, 2026NCT07903415
- Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain MetastasisOct 29, 2026NCT07904013
- Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular CarcinomaOct 29, 2026NCT07904494
- Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and First Diagnosis of Brain Metastases (HERBRAIN)Oct 29, 2026NCT07905313
- A Retrospective Registry of Intelliblate DUAL Channel Microwave AblationOct 28, 2026NCT07900984
- Aspirin and PAClitaxel in Head & Neck Squamous Cell CarcinomaOct 28, 2026NCT07901803
- ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek PopulationOct 27, 2026NCT07899463
- A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid TumorsOct 27, 2026NCT07899632
- An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid TumorsOct 26, 2026NCT07893535
- This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid TumorsOct 16, 2026NCT07878988
- BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based TherapyOct 13, 2026NCT07869836
- Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in JapanOct 13, 2026NCT07870837
Studies
Recruiting first, then most recently updated. Showing 50 of 4,040. Browse all 4,040 → or search them.
- Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 21 country
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyRecruitingNCT07423117Phase 11 country
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1RecruitingNCT07292168Phase 1/21 country
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsRecruitingNCT07020221Phase 1/24 countries
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 11 country
- A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic CancerNot yet recruitingNCT07928362Not applicable1 country
- Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer PatientsRecruitingNCT07928167Phase 21 country
- A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNot yet recruitingNCT07928037
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 317 countries
- BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based TherapyRecruitingNCT07869836Phase 31 country
- ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerRecruitingNCT07007559Phase 28 countries
- Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)RecruitingNCT079201981 country
- Tisotumab Vedotin in Squamous Cell Carcinoma of the VulvaNot yet recruitingNCT07672782Phase 21 country
- Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsRecruitingNCT05394103Phase 1/22 countries
- The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid CancerRecruitingNCT04927416Phase 21 country
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT000680031 country
- A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid TumorsRecruitingNCT07524140Phase 12 countries
- Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic CancerRecruitingNCT07829185Phase 11 country
- CREO - Microwave Ablation Feasibility StudyRecruitingNCT07817147Not applicable1 country
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07562152Phase 39 countries
- Implementing Precision Medicine in cOmmunity HospiTALsRecruitingNCT05283044Not applicable3 countries
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06983743Phase 13 countries
- Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact LabRecruitingNCT07860723Not applicable1 country
- A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)RecruitingNCT05384626Phase 1/215 countries
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic CancerNot yet recruitingNCT075284301 country
- A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate CancerRecruitingNCT066611221 country
- Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesRecruitingNCT07098806Phase 1/21 country
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06586957Phase 12 countries
- Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal CancerRecruitingNCT06824064Phase 23 countries
- Effect of Squatting Position in the Second Stage of Labor on Birth OutcomesRecruitingNCT07918872Not applicable1 country
- A Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT07029399Phase 11 country
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 17 countries
- Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaRecruitingNCT05726383Phase 21 country
- Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate CancerRecruitingNCT07751133Phase 31 country
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/22 countries
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)RecruitingNCT07174336Phase 319 countries
- Circulating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients With Resectable Colorectal Cancer Liver Metastases After ResectionRecruitingNCT07917104Phase 21 country
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 327 countries
- Change in Fat Fraction Quantification Before and After Treatment in Bone MetastasesRecruitingNCT078485161 country
- FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3RecruitingNCT05614739Phase 114 countries
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerRecruitingNCT06119581Phase 329 countries
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 18 countries
- Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate RetreatmentRecruitingNCT04143516Phase 2/31 country
- Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid TumorsRecruitingNCT05856981Phase 13 countries
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerRecruitingNCT04802759Phase 1/25 countries
- Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal CarcinomatosisRecruitingNCT07030283Phase 11 country
- This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid TumorsRecruitingNCT07878988Phase 11 country
- A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.RecruitingNCT07903415Phase 11 country
- FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor CancersRecruitingNCT07638371Phase 11 country
- Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue SarcomaRecruitingNCT07283731Phase 21 country